It's not just the availability that's the problem. Generic antibiotics sold in markets with little to no effective government oversight are often highly defecti

It's not just the availability that's the problem. Generic antibiotics sold in markets with little to no effective government oversight are often highly defective, with incredible variance between the active ingredient dosage listed on the label versus what's actually in the product itself. In most cases, the active ingredient contents are much lower than the label indicates, meaning that patients don't actually receive a therapeutically effective treatment unless they gamble on taking larger or more frequent doses than are indicated. Under-dosing in this manner creates excellent conditions for breeding resistant strains of bacteria.